Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic
Public ClinicalTrials.gov record NCT00696072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00696072
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Dasatinib Drug
- Letrozole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2008
- Primary completion
- May 31, 2014
- Completion
- May 31, 2014
- Last update posted
- Jun 12, 2016
2008 – 2014
United States locations
- U.S. sites
- 27
- U.S. states
- 11
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northern Arizona Hematology & Oncology Associates | Sedona | Arizona | 86336 | — |
| Arizona Oncology Associates D.B.A. Hematology Oncology | Tucson | Arizona | 85704 | — |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80220 | — |
| Florida Cancer Institute - New Hope | Hudson | Florida | 34667 | — |
| Central Indiana Cancer Centers | Carmel | Indiana | 46032 | — |
| New York Oncology Hematology, Pc | Troy | New York | 12180 | — |
| Dayton Oncology And Hematology | Kettering | Ohio | 45409 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists, Pc | Portland | Oregon | 97213 | — |
| Medical Oncology Associates | Kingston | Pennsylvania | 18704 | — |
| Texas Oncology-Central Austin Cancer Center | Austin | Texas | 78731 | — |
| Texas Oncology | Bedord | Texas | 76022 | — |
| Texas Cancer Center At Medical City | Dallas | Texas | 75230 | — |
| Texas Oncology | Dallas | Texas | 75231 | — |
| Texas Oncology Sammons Cancer Center | Dallas | Texas | 75246 | — |
| El Paso Cancer Treatment Ctr - East | El Paso | Texas | 79915 | — |
| Texas Oncology | Fort Worth | Texas | 76104 | — |
| Texas Oncology | Garland | Texas | 75042 | — |
| Texas Oncology | Houston | Texas | 77024 | — |
| Texas Oncology-Plano East | Plano | Texas | 75075 | — |
| Cancer Care Centers Of South Texas | San Antonio | Texas | 78217 | — |
| Texas Oncology Cancer Center - Sugar Land | Sugar Land | Texas | 77479 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology Cancer Care And Research Center | Waco | Texas | 76712 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Oncology & Hematology Associates Of Southwest Virginia, Inc. | Salem | Virginia | 24153 | — |
| Yakima Valley Memorial Hospital/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00696072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2016 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00696072 live on ClinicalTrials.gov.